Latest Restructuring News

Page 1 of 187
BCAL Diagnostics is prepared to support an expedited Genetic Signatures and Microba merger, but only on revised terms, a GSS board reset and protections for a superior proposal. It may also provide up to $2 million in working capital to Microba, subject to raising the funds itself.
Ada Torres
Ada Torres
19 Nov 2026
PlaySide Studios has emerged from a difficult year with a sharp EBITDA recovery, more than 1 million MOUSE sales and A$7.3 million of new FY27 external-project contracts. Its next test is converting that momentum into a successful Game of Thrones launch and more durable cash flow.
Victor Sage
Victor Sage
19 Nov 2026
Thrive Tribe Technologies has just A$20,000 of cash at 30 September and reported funding of only 0.0356 quarters, prompting an ASX-requested update to its quarterly disclosure. The company says restructuring will reduce cash outflows and plans to seek up to A$2 million after shareholder approval.
Sophie Babbage
Sophie Babbage
19 Nov 2026
Lifestyle Communities has entered FY27 with a substantially stronger balance sheet, after cutting net debt by $186.8 million and unsold inventory by 55% in FY26. The company says demand remains resilient, but slower Victorian property activity is stretching settlement timelines and tempering its next growth phase.
Eva Park
Eva Park
19 Nov 2026
Close the Loop has opened FY27 with $32.4 million in first-quarter revenue, $4.3 million in EBITDA and a substantial reduction in net debt. The company also expects a Citi refinancing to cut annual interest costs by about $1.4 million, although completion remains pending.
Victor Sage
Victor Sage
19 Nov 2026
Titomic will return to the Federal Court on November 26 for a second hearing on its proposed scheme of arrangement, three days after shareholders vote on the proposal. The court process is the next formal test for a transaction that could change the company’s corporate structure.
Victor Sage
Victor Sage
19 Nov 2026
An independent interim analysis has confirmed statistically significant iPPS benefits in Paradigm’s rest-of-world knee osteoarthritis cohort, giving the company a possible route to continue development despite the overall trial failing its futility test. Any new trial remains subject to funding, creditor approval and regulatory discussions.
Ada Torres
Ada Torres
19 Nov 2026
Nufarm has delivered a sharp FY26 recovery in underlying earnings and cash generation, with leverage falling to 2.0 times despite a 7% revenue decline. The statutory loss, no ordinary dividend and ongoing restructuring show the turnaround remains unfinished.
Ada Torres
Ada Torres
19 Nov 2026
Worley has reaffirmed mid to high single-digit growth expectations for FY2027 despite a weaker FY2026, while shareholders delivered a strong protest vote on executive remuneration. The AGM also began the search for a successor to long-serving Chair John Grill.
Victor Sage
Victor Sage
19 Nov 2026
Schaffer Corporation maintained its fully franked dividend at $0.90 per share despite a 9% fall in FY26 statutory profit, with Delta expected to remain loss-making in the first half of FY27. Automotive Leather has recovered from last year’s disruption, while South Connect Jandakot is becoming an increasingly important earnings and asset-value driver.
Victor Sage
Victor Sage
18 Nov 2026
Australian Vintage says its FY26 turnaround has restored positive free cash flow excluding growth investments, while Poco Vino sales and international expansion gather pace. The wine group is targeting a return to net cash in FY27, but has also withdrawn its 2040 net-zero emissions target.
Victor Sage
Victor Sage
18 Nov 2026
Ecolab is expanding its One Ecolab programme and expects US$600 million in combined restructuring costs and special charges through 2030. Most restructuring spending is expected to be cash severance costs as teams are shifted into global centres of excellence.
Maxwell Dee
Maxwell Dee
18 Nov 2026

Browse the archive

Full archive